Jazz Pharmaceuticals is dedicated to developing life-changing medicines for people with limited or
no options, so they can live their lives more fully.
As a leader in sleep medicine with a growing neuroscience and hematology/oncology treatment
portfolio, Jazz has a diverse pipeline of products and product candidates in development, and is
focused on transforming biopharmaceutical discoveries into novel medicines.
In addition to our innovative research and growing portfolio of medicines, Jazz is also committed to
addressing unmet needs in sleep medicine by improving awareness and accurate diagnosis of
narcolepsy and excessive sleepiness in obstructive sleep apnea (OSA).
Jazz is the industry leader in sleep medicine innovation in the U.S. with a growing R&D program
focused on enhancing our current therapies and developing new treatments for patients with
chronic and often debilitating sleep and neurological disorders.
- Multiple offices in Europe and North America
- Headquarters in Dublin, Ireland UK office in Oxford
- Manufacturing operations in Ireland and Italy